Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy?

Eli Lilly (LLY) and AstraZeneca (AZN) are leading drugmakers with significant involvement in oncology, immunology, and the cardiometabolic disease space. Both are making substantial investments in next-generation therapies such as cancer immunotherapies, treatments for respiratory conditions as well as GLP-1 drugs. With robust, research-driven pipelines and strong growth potential, they represent an intriguing comparison for investors considering large-cap pharmaceutical stocks.Though both companies have a ...